Levitzki A - Search Results

1

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.

Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, Kuriyan J. Schindler T, et al. Among authors: levitzki a. Mol Cell. 1999 May;3(5):639-48. doi: 10.1016/s1097-2765(00)80357-3. Mol Cell. 1999. PMID: 10360180 Free article.

2

Tyrosine kinase inhibition: an approach to drug development.

Levitzki A, Gazit A. Levitzki A, et al. Science. 1995 Mar 24;267(5205):1782-8. doi: 10.1126/science.7892601. Science. 1995. PMID: 7892601 Review.

3

Distinct roles of the receptor tyrosine kinases c-ErbB and c-Kit in regulating the balance between erythroid cell proliferation and differentiation.

Wessely O, Mellitzer G, von Lindern M, Levitzki A, Gazit A, Ischenko I, Hayman MJ, Beug H. Wessely O, et al. Among authors: levitzki a. Cell Growth Differ. 1997 May;8(5):481-93. Cell Growth Differ. 1997. PMID: 9149900

4

Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.

Posner I, Engel M, Gazit A, Levitzki A. Posner I, et al. Among authors: levitzki a. Mol Pharmacol. 1994 Apr;45(4):673-83. Mol Pharmacol. 1994. PMID: 8183246

5

Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.

Mazumder A, Gazit A, Levitzki A, Nicklaus M, Yung J, Kohlhagen G, Pommier Y. Mazumder A, et al. Among authors: levitzki a. Biochemistry. 1995 Nov 21;34(46):15111-22. doi: 10.1021/bi00046a018. Biochemistry. 1995. PMID: 7578125

6

The pp60c-Src inhibitor PP1 is non-competitive against ATP.

Karni R, Mizrachi S, Reiss-Sklan E, Gazit A, Livnah O, Levitzki A. Karni R, et al. Among authors: levitzki a. FEBS Lett. 2003 Feb 27;537(1-3):47-52. doi: 10.1016/s0014-5793(03)00069-3. FEBS Lett. 2003. PMID: 12606029 Free article.

7

Substrate competitive inhibitors of IGF-1 receptor kinase.

Blum G, Gazit A, Levitzki A. Blum G, et al. Among authors: levitzki a. Biochemistry. 2000 Dec 26;39(51):15705-12. doi: 10.1021/bi001516y. Biochemistry. 2000. PMID: 11123895

8

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. Garcia R, et al. Among authors: levitzki a. Oncogene. 2001 May 3;20(20):2499-513. doi: 10.1038/sj.onc.1204349. Oncogene. 2001. PMID: 11420660

9

Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins.

Anafi M, Gazit A, Gilon C, Ben-Neriah Y, Levitzki A. Anafi M, et al. Among authors: levitzki a. J Biol Chem. 1992 Mar 5;267(7):4518-23. J Biol Chem. 1992. PMID: 1537837 Free article.

10

The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.

Dvir A, Milner Y, Chomsky O, Gilon C, Gazit A, Levitzki A. Dvir A, et al. Among authors: levitzki a. J Cell Biol. 1991 May;113(4):857-65. doi: 10.1083/jcb.113.4.857. J Cell Biol. 1991. PMID: 1709168 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters